"Now it's up to us to look where can we accelerate our portfolio, in which areas and where can we grow the most and deliver good value for our customers,” says CEO Andreas Fibig.
Supplying flavors, fragrances and ingredients for nutritional, cosmetic and pharma product manufacturers has changed, and International Flavors & Fragrances Inc. has changed to meet market demand, notably by acquiring DuPont Nutrition & Biosciences, says CEO Andreas Fibig.
“With our transaction with the N&B – DuPont's N&B business – we have made a significant step forward. First of all, we ramped up our game in research and development
Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.
Swedish producer of antioxidant astaxanthin AstaReal has expanded its product offering with cardiovascular health focused-brand Kyolic.
Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.
Azelis adds dietary supplement ingredients and a large customer base across Spain to its portfolio with the acquisition of Solchem Nature.
Herbalife expects little impact from increased tariffs on imports from China but strong boosts from acquiring Pro2col Health and Pruvit Ventures Inc. and 51% ownership of Link BioSciences.
Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.
US dietary supplement brand Nature's Bounty is yet to fully recover sales since supply issues forced it off shelves last year, according to Nestle's Q1 report.
